Nvidias Blockbuster Earnings Highlight 200 Billion Edge Computing Opportunity as China Market Fades Enterprise Products Partners EPD Receives Higher Price Target Amid Mixed Analyst Sentiment Mint and Rice Robotics Joint Venture Aims to Expand AI Companion Robot Business with HK15M Funding SPIC Reports Higher Q4 Profit on Improved Cost Management FullYear Net Income Rises Grayscale Identifies Four Altcoins Poised to Benefit From the CLARITY Act ASML Holding NV Deepens India Presence Through Tata Electronics Partnership Bridgeline Digital Q1 2026 Earnings EPS Misses Estimates Amidst Significant Surprise Utah Medical Products Inc UTMD Q1 2024 Earnings EPS of 109 Reported Stock Gains Modestly TLPH Q1 2026 Earnings Significant EPS Beat as PreRevenue Biotech Advances Pipeline Boyd Gaming BYD Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment TrioTech International TRT Q3 2024 Earnings Modest Profit Reported Amidst Challenging Environment Werewolf Therapeutics HOWL Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Discipline Flutter Entertainment FLUT Slides 18 as Selling Pressure Tests Key Support Levels Tvardi Therapeutics TVRD Holds Steady Near Support Amid LowVolume Trading Zscaler Plunges Over 31 Key Support and Resistance Levels for ZS Stock Alpha Pro Tech Ltd APT Gains Ground as Technical Levels Come into Focus SEATW Holds Steady at 006 Amid Minimal Activity Vivid Seats Warrant Remains RangeBound Trump Seeks Supreme Court Intervention to Delay TikTok Ban CCLD Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines BranchOut Food Inc BOF Surges 4 as Buyers Test Key Resistance at 345 Alcon Inc Ordinary Shares ALC Q1 2026 Earnings EPS Beat Drives Optimism but Stock Edges Lower Bioventus BVS Q1 2026 Earnings Strong EPS Beat Amidst Market Skepticism VC Q1 2026 Earnings EPS Beat Surprises Market Shares Jump 29 NetSTREIT Corp NTST Q1 2026 Earnings EPS Misses Street View Shares Dip on Weaker Profitability WNC Q1 2026 Earnings EPS Misses Estimates Amid Persistent Headwinds AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs ET Q1 2026 Earnings Earnings Miss Expectations as Margin Pressures Persist